Dynavax Technologies Corp (DVAX)
11.16
-0.26
(-2.23%)
USD |
NASDAQ |
Apr 25, 16:00
11.16
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies Accounts Payable (Quarterly): 5.245M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.245M |
September 30, 2023 | 3.12M |
June 30, 2023 | 3.246M |
March 31, 2023 | 7.296M |
December 31, 2022 | 3.211M |
September 30, 2022 | 3.05M |
June 30, 2022 | 4.959M |
March 31, 2022 | 20.19M |
December 31, 2021 | 2.60M |
September 30, 2021 | 3.596M |
June 30, 2021 | 12.08M |
March 31, 2021 | 3.154M |
December 31, 2020 | 3.312M |
September 30, 2020 | 5.273M |
June 30, 2020 | 2.695M |
March 31, 2020 | 4.557M |
December 31, 2019 | 9.278M |
September 30, 2019 | 7.66M |
June 30, 2019 | 11.23M |
March 31, 2019 | 11.87M |
December 31, 2018 | 5.278M |
September 30, 2018 | 4.089M |
June 30, 2018 | 3.314M |
March 31, 2018 | 2.279M |
December 31, 2017 | 4.539M |
Date | Value |
---|---|
September 30, 2017 | 2.243M |
June 30, 2017 | 0.681M |
March 31, 2017 | 1.466M |
December 31, 2016 | 3.796M |
September 30, 2016 | 3.795M |
June 30, 2016 | 4.486M |
March 31, 2016 | 3.476M |
December 31, 2015 | 3.433M |
September 30, 2015 | 2.359M |
June 30, 2015 | 2.345M |
March 31, 2015 | 3.272M |
December 31, 2014 | 1.159M |
September 30, 2014 | 4.972M |
June 30, 2014 | 1.90M |
March 31, 2014 | 1.863M |
December 31, 2013 | 1.901M |
September 30, 2013 | 1.289M |
June 30, 2013 | 1.253M |
March 31, 2013 | 1.727M |
December 31, 2012 | 2.166M |
September 30, 2012 | 1.578M |
June 30, 2012 | 1.155M |
March 31, 2012 | 2.358M |
December 31, 2011 | 2.04M |
September 30, 2011 | 1.313M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.60M
Minimum
Dec 2021
20.19M
Maximum
Mar 2022
6.092M
Average
4.557M
Median
Mar 2020
Accounts Payable (Quarterly) Benchmarks
Supernus Pharmaceuticals Inc | 1.964M |
Ligand Pharmaceuticals Inc | 2.427M |
Pacira BioSciences Inc | 15.70M |
Esperion Therapeutics Inc | 31.72M |
PetIQ Inc | 139.26M |